Windtree Therapeutics Inc WINT.O:
WINDTREE THERAPEUTICS INC - INTERIM ANALYSIS TO ASSESS SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY
WINDTREE THERAPEUTICS INC - REACHES PLANNED ENROLLMENT OF 20 PATIENTS FOR SEISMIC C STUDY
WINDTREE THERAPEUTICS INC - DATA EXPECTED TO BE USEFUL FOR END OF PHASE 2 MEETING WITH FDA
Source text: ID:nGNX86K8CL
Further company coverage: WINT.O
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.